Cargando…

Prevalence and Fracture Risk of Osteoporosis in Patients with Rheumatoid Arthritis: A Multicenter Comparative Study of the FRAX and WHO Criteria

(1) Background: We evaluated the prevalence and fracture risk of osteoporosis in patients with rheumatoid arthritis (RA), and compared the fracture risk assessment tool (FRAX) criteria and bone mineral density (BMD) criteria established by the World Health Organization (WHO). (2) Methods: This retro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Choi, Sang Tae, Kwon, Seong-Ryul, Jung, Ju-Yang, Kim, Hyoun-Ah, Kim, Sung-Soo, Kim, Sang Hyon, Kim, Ji-Min, Park, Ji-Ho, Suh, Chang-Hee
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6306752/ https://www.ncbi.nlm.nih.gov/pubmed/30513848 http://dx.doi.org/10.3390/jcm7120507

Ejemplares similares

Prevalence of osteoporosis in patients with systemic lupus erythematosus: A multicenter comparative study of the World Health Organization and fracture risk assessment tool criteria
por: Jung, Ju-Yang, et al.
Publicado: (2020)

Clinical Impact of the Fracture Risk Assessment Tool on the Treatment Decision for Osteoporosis in Patients with Knee Osteoarthritis: A Multicenter Comparative Study of the Fracture Risk Assessment Tool and World Health Organization Criteria
por: Kim, Bo Young, et al.
Publicado: (2019)

Prevalence and Factors of Osteoporosis and High Risk of Osteoporotic Fracture in Patients with Ankylosing Spondylitis: A Multicenter Comparative Study of Bone Mineral Density and the Fracture Risk Assessment Tool
por: Kim, Ji-Won, et al.
Publicado: (2022)

The Risk of Osteoporotic Fractures According to the FRAX Model in Korean Patients with Rheumatoid Arthritis
por: Lee, Jae Ho, et al.
Publicado: (2014)

Positive Effects of Biologics on Osteoporosis in Rheumatoid Arthritis
por: Kim, Yunkyung, et al.
Publicado: (2023)

Factors Determining Retreatment Time Interval of Rituximab in Korean Patients With Rheumatoid Arthritis
por: Kim, Ji-Won, et al.
Publicado: (2021)

The Assessment of Muscle Mass and Function in Patients with Long-Standing Rheumatoid Arthritis
por: Yun, Hye-Won, et al.
Publicado: (2021)

Anti-Inflammatory Effects of Low-Dose Glucocorticoids Compensate for Their Detrimental Effects on Bone Mineral Density in Patients with Rheumatoid Arthritis
por: Kim, Ji-Won, et al.
Publicado: (2021)

Biologic therapy for amyloid A amyloidosis secondary to rheumatoid arthritis treated with interleukin 6 therapy: Case report and review of literature
por: Jung, Ju-Yang, et al.
Publicado: (2021)

Male patients with rheumatoid arthritis have an increased risk of osteoporosis: Frequency and risk factors
por: Kweon, Seong-Min, et al.
Publicado: (2018)

Unveiling difficult-to-treat rheumatoid arthritis: long-term impact of biologic or targeted synthetic DMARDs from the KOBIO registry
por: Jung, Ju-Yang, et al.
Publicado: (2023)

Effect of Vitamin D Supplementation on Bone Mineral Density in Rheumatoid Arthritis Patients With Osteoporosis
por: Kwon, Oh Chan, et al.
Publicado: (2020)

FRAX-Based Intervention Thresholds for Osteoporosis Treatment in Ukraine
por: Povoroznyuk, Vladyslav, et al.
Publicado: (2021)

A Comparison of Three Different Guidelines for Osteoporosis Treatment in Patients with Rheumatoid Arthritis in Korea
por: Yoon, Jiyeol, et al.
Publicado: (2010)

Comparison of remission criteria in patients with rheumatoid arthritis treated with biologic or targeted synthetic disease-modifying anti-rheumatic drugs: results from a nationwide registry
por: Koh, Jung Hee, et al.
Publicado: (2022)

Application of the international league against rheumatism classification criteria for systemic juvenile idiopathic arthritis as a prognostic factor in patients with adults-onset Still’s disease
por: Yang, Ji Won, et al.
Publicado: (2018)

The Role of Bone Scintigraphy in the Diagnosis of Rheumatoid Arthritis According to the 2010 ACR/EULAR Classification Criteria
por: Kim, Ji Young, et al.
Publicado: (2014)

Serum Pro-hepcidin Could Reflect Disease Activity in Patients with Rheumatoid Arthritis
por: Kim, Hae-Rim, et al.
Publicado: (2010)

Compliance and persistence with oral bisphosphonates for the treatment of osteoporosis in female patients with rheumatoid arthritis
por: Park, Ji-Heh, et al.
Publicado: (2017)

The frequency of and risk factors for osteoporosis in Korean patients with rheumatoid arthritis
por: Lee, Joo-Hyun, et al.
Publicado: (2016)

Injectable Gold-Induced Hepatitis and Neutropenia in Rheumatoid Arthritis
por: Uhm, Wan-Sik, et al.
Publicado: (2000)

Rheumatoid arthritis and the risk of end-stage renal disease: A nationwide, population-based study
por: Suh, Sang Heon, et al.
Publicado: (2023)

The comparable efficacy of denosumab on bone mineral density in rheumatoid arthritis patients with postmenopausal osteoporosis: A retrospective case-control study
por: Kim, Seong-Kyu, et al.
Publicado: (2023)

Sleep quality in rheumatoid arthritis, and its association with disease activity in a Korean population
por: Son, Chang-Nam, et al.
Publicado: (2015)

Association between brain-derived neurotrophic factor gene polymorphisms and fibromyalgia in a Korean population: a multicenter study
por: Park, Dong-Jin, et al.
Publicado: (2018)

Subpopulations of Regulatory T Cells in Rheumatoid Arthritis, Systemic Lupus Erythematosus, and Behcet's Disease
por: Kim, Jae-Ryong, et al.
Publicado: (2012)

Systemic Manifestations and Complications in Patients with Rheumatoid Arthritis
por: Kim, Ji-Won, et al.
Publicado: (2020)

Mikkeli Osteoporosis Index Identifies Fracture Risk Factors and Osteoporosis and Intervention Thresholds Parallel with FRAX
por: Waris, Ville Juhana, et al.
Publicado: (2011)

ADAM17 Genetic Variants and the Response of TNF-α Inhibitor in Rheumatoid Arthritis Patients
por: Kim, Hyun Jeong, et al.
Publicado: (2020)

Gout as a risk factor for osteoporosis: A Korean population-based study
por: Kim, Ji Hyoun, et al.
Publicado: (2022)

Are glucocorticoid-induced osteoporosis recommendations sufficient to determine antiosteoporotic treatment for patients with rheumatoid arthritis?
por: Lee, Joo-Hyun, et al.
Publicado: (2014)

Medication nonadherence in Korean patients with rheumatoid arthritis: the importance of belief about medication and illness perception
por: Suh, Young Sun, et al.
Publicado: (2018)

Clarifying WHO’s position on the FRAX® tool for fracture prediction
por: Ford, Nathan, et al.
Publicado: (2016)

Tocotrienol regulates osteoclastogenesis in rheumatoid arthritis
por: Kim, Kyoung-Woon, et al.
Publicado: (2021)

Trabecular bone score as a supplementary tool for the discrimination of osteoporotic fractures in postmenopausal women with rheumatoid arthritis
por: Choi, Yong Jun, et al.
Publicado: (2017)

Corrigendum to “Mikkeli Osteoporosis Index Identifies Fracture Risk Factors and Osteoporosis and Intervention Thresholds Parallel with FRAX”
por: Waris, Ville Juhana, et al.
Publicado: (2017)

Response to comment on “Medication nonadherence in Korean patients with rheumatoid arthritis: the importance of belief about medication and illness perception”
por: Suh, Young Sun, et al.
Publicado: (2018)

Treat-to-Target Strategy for Asian Patients with Early Rheumatoid Arthritis: Result of a Multicenter Trial in Korea
por: Song, Jason Jungsik, et al.
Publicado: (2018)

Cost-effectiveness of FRAX®-based intervention thresholds for management of osteoporosis in Singaporean women
por: Chandran, M., et al.
Publicado: (2020)

Comparison between real-world practice and application of the FRAX algorithm in the treatment of osteoporosis
por: Zoccarato, Francesca, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1gjgu5935ksmoifcl5t6pprmkk